openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings sections page 1 of 1 · 1 matching rows.
warnings
WARNING Folic acid alone is improper therapy in the treatment of pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. Ingestion of omega-3 fatty acids (including alpha-linolenic acid (ALA), elecosapentaenoic acid [EPA] and docosahexaenoic acid [DHA] from fish oils) of more than 3 grams per day may present antithrombotic effects, including increased bleeding time. Omega-3 fatty acids including DHA and EPA should be avoided in patients with inherited or acquired bleeding diatheses. Patients taking anticoagulant drug products should consult with their physician prior to ingesting omega-3 fatty acids.
ADVERSE REACTIONS Iron: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) can occur but are usually mild and can subside with continuation of therapy. Although the absorption of iron is best when taken between meals, Renate DHA 275/400 mg, when taken after meals, may control occasional G.I. disturbances, Renate DHA 275/400 mg is best absorbed when taken at bedtime. Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid. Call your doctor for medical advice about side effects. You may report suspected side effects to the FDA at: 1-800-FDA-1088.